Home Luteolin alleviates ulcerative colitis in rats via regulating immune response, oxidative stress, and metabolic profiling
Article Open Access

Luteolin alleviates ulcerative colitis in rats via regulating immune response, oxidative stress, and metabolic profiling

  • Bolin Li , Yuxi Guo , Xuemei Jia , Yanru Cai , Yunfeng Zhang EMAIL logo and Qian Yang EMAIL logo
Published/Copyright: August 30, 2023
Download Article (PDF)
Open Medicine
From the journal Open Medicine Volume 18 Issue 1

Abstract

Ulcerative colitis (UC) is an inflammatory bowel disease and associated with metabolic imbalance. Luteolin (LUT) reportedly exhibits anti-inflammatory activity. However, its regulatory effects on metabolites remain indistinct. Here, the effects of LUT on immune response and oxidative stress in UC were determined. Serum metabolomics profiles of UC rats treated with LUT were obtained utilizing liquid chromatography-mass spectrometry. The results revealed that LUT treatment alleviated colon tissue injury, colon shortening, weight loss, and inflammatory response in UC rats. Additionally, the levels of superoxide dismutase and total antioxidant capacity were elevated, but malondialdehyde content was reduced in serum of UC rats, while these changes were abrogated by LUT. Metabolomics analysis unveiled that l-malic acid, creatinine, l-glutamine, and l-lactic acid levels were remarkably decreased, while dimethyl sulfone, 5-methylcytosine, cysteine-S-sulfate, and jasmonic acid levels were notably increased after LUT treatment. Furthermore, differential metabolites primarily participated in d-glutamine and d-glutamate metabolism, glutathione metabolism, and citrate cycle pathways. In summary, these results demonstrated that LUT improved immune response, alleviated oxidative stress, and altered metabolites in UC rats. This study lays the root for further exploring the mechanism of LUT in the treatment of UC.

Keywords: ulcerative colitis; luteolin; oxidative stress; immune response; metabolomics; liquid chromatography-mass spectrometry

1 Introduction

Ulcerative colitis (UC) is a chronic inflammatory disease that influences the colon, and usually presents with abdominal pain and bloody diarrhea [1]. The pathogenesis of UC includes multiple factors such as heredity, epithelial barrier defect, immune response disorder, and environment [2]. At present, the incidence of UC is on the rise in the world [3]. Approximately 95% of cases involve the rectum and develop continuously in a symmetrical, circumferential pattern to the vicinity, involving part or all of the large intestine [4]. Up to 15% of patients with UC require colectomy [2]. The common approaches for treating UC mainly included antibiotics, 5-aminosalicylates, glucocorticoids, and immune-mediators [5,6]. However, these drugs exert numerous limitations, including adverse side effects and economic burden. Thus, it is necessary to find a novel treatment which overcomes the shortcomings of the current treatments.

Luteolin (LUT) is a natural flavonoid compound and is widely found in many plants, including pepper, carrot, chamomile, celery, and spinach [7,8]. LUT has been reported to have antioxidant, antiviral, anti-inflammatory and anti-cancer properties [9]. In the anti-inflammatory studies of LUT, LUT was found to reduce the damage of bronchopneumonia, inhibit the inflammasome, reduce neutrophilic inflammation, treat osteoarthritis, reduce the inflammatory phenotype of high-glucose induced cardiomyocytes, and prevent non-alcoholic steatohepatitis [10–15]. Evidence revealed that LUT has a protective effect against UC [16]. However, the therapeutic mechanism of LUT in UC has not been fully elucidated.

In recent years, metabolomics has been developed rapidly. Metabolomics analysis can significantly improve the chance of finding disease-related biomarkers [17]. Zhang et al. compared UC patients with controls and found that UC patients showed increased 3-hydroxyl, β-glucose, d-glucose, and phenylalanine, but decreased serum lipids [18]. Bjerrum et al. found that leucine, isoleucine, valine, and lysine increased in feces of UC patients [19]. These findings indicated that metabolites were associated with the development UC. Liquid chromatography-mass spectrometry (LC-MS) has been widely used in recent years because of its advantages of high sensitivity, strong specificity, and simple sample treatment [20]. Metabolomics analysis of urine and feces sample in UC rats by using LC-MS revealed that Berberine could improve metabolic disorders [21]. However, the profiles and differences of serum metabolites of UC rats regulated by LUT have not been reported.

In this study, we aimed to explore the function of LUT in immune response, oxidative stress, and metabolites in UC rats. UC model was established by employing dextran sulfate sodium (DSS) administration in rats. The metabolic profiles and potential metabolites in the UC rats after LUT treatment were investigated by using LC-MS. This study offers a basis for the potential metabolic mechanism of LUT in UC.

2 Materials and methods

2.1 Animals

Eight-week-old male Wistar rats (200 ± 20 g) were obtained from Hebei Provincial Hospital of Chinese Medicine (Animal number: SCXK(Ji)2018-004). All rats were grown in a specific pathogen-free room with 40–50% humidity and 12 h/12 h dark/light cycle at 22–24°C. They had free access to food and water ad libitum. All rats were adapted to environment for a week before experiment.

2.2 Induction of UC and animal treatment

The UC rat model was induced by DSS (Dalian Meilun Biotechnology Co., LTD, China). The rats were randomly segmented into four groups (n = 10 each group): normal control group (NC group), model group (MOD group), mesalazine (MES) group, and LUT group. MES was used as a positive control. The rats of the NC group were given drinking water. The rats of the MOD, MES, and LUT groups were given 3.5% DSS solution for continuous 10 days to build UC model rats [22]. After the UC model was successfully established, rats in the MES group were administrated intragastrically with MES suspension (Losan Pharma GmbH, Freiburg im Breisgau, Germany) at a usage of 0.315 g/kg/day once daily for 14 days based on our preliminary experiment. Rats in the LUT group were administrated intragastrically with LUT suspension (Shanghai Winherb Medical Technology Co., Ltd, China) at usage of 34.6 mg/kg/day once daily for 14 days based on our preliminary experiment. Rats in the NC group and MOD group were given the same dose of normal sodium chloride. Fourteen days after treatment, the rats were fasted for 24 h. No rats died in the NC group and the LUT group. One rat died in the MOD group and one rat died in the MES group during the treatment. Then rats were injected with 1% pentobarbital sodium (50 mg/kg) intraperitoneally. All rats were sacrificed at the end of experiment for collecting colon tissues and serum. The samples were stored at −80°C until use.

2.3 Enzyme-linked immunosorbent assay (ELISA)

The levels of TNF-α, C-reactive protein (CRP), IL-13, IL-33, and suppression of tumorigenicity 2 (ST2) in the serum were measured using corresponding ELISA kits (Boster Biological Technology Co. Ltd, USA) in accordance with the instructions from the manufacturer.

2.4 Hematoxylin–eosin (H&E) staining

The pathological changes in colon tissues of rats were evaluated by H&E staining. Briefly, colon tissues were fixed in 10% buffered formaldehyde (Shanghai Biotechnology Co. Ltd, Shanghai, China), dehydrated, and embedded in paraffin. The colon segments was sliced with a thickness of 4 μm, dewaxed in xylene, and rehydrated. Subsequently, the sections were stained with H&E. In the end, the sections were dehydrated in gradient ethanol, vitrified by xylene, and sealed with neutral balsam. The images were observed utilizing a light microscope (LEICA DM500, Wetzlar, Germany).

2.5 Immunohistochemistry

The paraffin sections were deparaffinized, rehydrated in alcohol. After soaking in 3% H2O2, the sections were boiled in 0.01 M sodium citrate buffer for antigen retrieval. The sections were blocked with 5% BSA and incubated with primary antibody against CD4 (1:2,000; Abcam, UK) and CD8 (1:2,000; Abcam, UK) overnight at 4°C. After washing four times with PBS, a secondary antibody (1:2,000; Abcam, UK) was added and the sections were incubated for 35 min at 37°C. In the end, the sections were stained with 3,3′-diaminobenzidine tetrahydrochloride and hematoxylin. The samples were dehydrated and mounted. Images were observed by employing a microscope (OLYMPUS CK31, Japan).

2.6 Assessment of oxidative stress

The level of superoxide dismutase (SOD), malondialdehyde (MDA), and total antioxidant capacity (T-AOC) in the serum of rats was measured employing SOD (ml059387-1, Shanghai EnzymeLinked Biotechnology, China), MDA (S0131S, Beyotime, China), and T-AOC (S0121, Beyotime, China) assay kits. After detecting the absorbance at 450 nm, the SOD, MDA, and T-AOC content was calculated following the manufacturer’s instructions.

2.7 Metabolite extraction and LC-MS

Samples were melted at 4°C. After 100 µL of each sample was transferred into 2 mL centrifuge tubes and added with 100 µL of mixed internal standard solution and 400 µL of methanol, the tubes were vortexed for 1 min. Subsequently, the samples were centrifuged at 4°C for 10 min at 12,000 rpm, and 500 µL of the supernatant was transferred into a new 2 mL centrifuge tube. Samples were concentrated to dry and dissolved with 150 µL of 80% methanol solution. Finally, centrifugation was performed to obtain the supernatant for LC-MS.

Chromatography was carried out in an Thermo Vanquish (Thermo, MA, USA) system, which had an ACQUITY UPLC® HSS T3 (150 × 2.1 mm, 1.8 µm, waters) column. The temperature of the autosampler and column was 8 and 40°C, respectively. Gradient elution of samples was conducted with 0.1% formic acid in water and 0.1% formic acid acetonitrile or 5 mM ammonium formate in water and acetonitrile.

The ESI-MSn experiments were performed on the Thermo Q Exactive mass spectrometer (Massachusetts, USA). MS parameters were set as follows: the spray voltage was 3.5 kV in positive modes and 2.5 kV in negative modes. The capillary temperature was 325°C. The scanned range was m/z 81–1,000 with a resolution ratio of 70,000. Data were acquired in data-dependent acquisition mode or MS/MS mode to get detailed information of the compounds.

2.8 Metabolite identification and metabolic pathway enrichment analysis

The raw data were transformed into mzXML format through Proteowizard software (v3.0.8789). R package (v3.3.2) was employed for peaks identification, peaks filtration, and peaks alignment. Mass to charge ratio, retention time, and intensity were obtained and batch normalization of these data was conducted. Afterward, quality control and quality assurance were carried out to obtain high-quality metabolomics data. Partial least-squares discriminant analysis (PLS-DA) was utilized to determine the altered compounds of all samples. The relevant differential metabolite screening criteria were P-value ≤ 0.05 and VIP ≥ 1. The identification of metabolites was first determined following the precise molecular weight, and then annotated with Metlin database and MoNA database. MetaboAnalyst and Kyoto Encyclopedia of Genes and Genomes (KEGG) were utilized to analyze the metabolic pathways.

2.9 Statistical analysis

SPSS 19.0 was utilized to analyze data and data were displayed as mean ± standard deviation (SD). The one-way analysis of variance followed by Tukey’s post hoc test was selected to detect the statistical significance of more than two groups. P-value less than 0.05 was deemed to be statistically significant.

  1. Ethics statement: All rat’s experiments were approved by the Ethical Committee and the Animal Experimental Committee of Hebei Provincial Hospital of Chinese Medicine.

3 Results

3.1 LUT protects DSS-induced colitis rats from colonic damage

To ascertain the function of LUT in histological changes of UC rats, the colon tissues of rats were observed. As displayed in Figure S1a, the appearance of colorectal was normal in the NC group. Compared with the NC group, the colorectal length in the MOD group was shortened, the intestinal cavity was filled with dark red feces, and part of the intestinal wall was thinner (Figure S1b). The colorectal lengths of rats in the MES group and the LUT group were improved (Figure S1c and d). The UC rats demonstrated decreased body weight compared with the normal rats. The administration of MES or LUT resulted in an increase in body weight in UC rats (Table S1). HE staining indicated that the structure the colon of rats was intact and clear without inflammation and ulcer in the NC group. The glands were arranged regularly (Figure 1a). In the MOD group, the colonic epithelial structure, crypt structure, and epithelial integrity of rats were destroyed. The glands are badly damaged with submucosal edema and a large number of inflammatory cell infiltration (Figure 1b). After treatment with either MES or LUT, the colonic mucosal epithelium of rats was basically intact, the edema and destruction of crypt were alleviated, and inflammatory cell infiltration was obviously reduced in UC rats (Figure 1c and d). These data demonstrated that LUT could ease colonic damage of UC rats.

Figure 1 Effects of LUT on the histological changes in UC rats. Histological changes of rats in (a) normal control (NC), (b) model (MOD), (c) mesalazine (MES), and (d) luteolin (LUT) group were observed by HE staining (100× magnification).
Figure 1

Effects of LUT on the histological changes in UC rats. Histological changes of rats in (a) normal control (NC), (b) model (MOD), (c) mesalazine (MES), and (d) luteolin (LUT) group were observed by HE staining (100× magnification).

3.2 LUT improves immune response in the UC rats

To investigate the effects of LUT on inflammation, we examined the levels of inflammatory factors, including TNF-α, CRP, IL-13, IL-33, and ST-2 by ELISA. In comparison with the NC group, the levels of TNF-α, CRP, IL-13, IL-33, and ST-2 were remarkably elevated in the MOD group. Nevertheless, LUT administration prominently lowered these inflammatory factors in UC rats (Figure 2a). In addition, the immunohistochemistry was used to detect the levels of CD4+ T and CD8+ T cells. The proportion of CD8+ T cells was strikingly increased, whereas CD4+ T cells was markedly decreased in UC rat relative to the NC group. In contrast, LUT administration resulted in a prominent reduction in the ratio of CD8+ T cells and a dramatical increase in the ratio of CD4+ T cells (Figure 2b and c). Collectively, these results uncovered that LUT improves immune response in UC rats.

Figure 2 Effects of LUT on inflammation and immune response in UC rats. (a) Expression levels of TNF-α, CRP, IL-13, IL-33, and ST-2 were examined by ELISA. (b) Representative image of CD4+ T cell staining in the colon (100× magnification). (c) Representative image of CD8+ T cell staining (100× magnification). NC represents normal control. MOD represents model. MES represent mesalazine. LUT represents luteolin. There were 10, 8, 8, and 9 replicates in NC, MOD, MES, and LUT groups, respectively. **P < 0.01 vs the NC group. #P < 0.05 and ##P < 0.01 vs the MOD group.
Figure 2

Effects of LUT on inflammation and immune response in UC rats. (a) Expression levels of TNF-α, CRP, IL-13, IL-33, and ST-2 were examined by ELISA. (b) Representative image of CD4+ T cell staining in the colon (100× magnification). (c) Representative image of CD8+ T cell staining (100× magnification). NC represents normal control. MOD represents model. MES represent mesalazine. LUT represents luteolin. There were 10, 8, 8, and 9 replicates in NC, MOD, MES, and LUT groups, respectively. **P < 0.01 vs the NC group. #P < 0.05 and ##P < 0.01 vs the MOD group.

3.3 LUT inhibits oxidative stress in UC rats

We assessed the function of LUT in oxidative stress in UC rats. As displayed in Figure 3, the levels of SOD and T-AOC were obviously decreased and the MDA concentration was remarkably increased in UC rats relative to the NC group. On the contrary, their expressions were reversed by LUT treatment. These results indicated that LUT alleviated oxidative stress in UC rats.

Figure 3 Effects of LUT on oxidative stress in UC rats. The levels of (a) SOD, (b) MDA, and (c) T-AOC in serum were detected by SOD, MDA, and T-AOC assay kits, respectively. Results are shown as the mean ± SD. NC represents normal control. MOD represents model. MES represent mesalazine. LUT represents luteolin. There were 10, 8, 8, and 9 replicates in NC, MOD, MES, and LUT groups, respectively. **P < 0.01 vs NC group. #P < 0.05 and ##P < 0.01 vs the MOD group.
Figure 3

Effects of LUT on oxidative stress in UC rats. The levels of (a) SOD, (b) MDA, and (c) T-AOC in serum were detected by SOD, MDA, and T-AOC assay kits, respectively. Results are shown as the mean ± SD. NC represents normal control. MOD represents model. MES represent mesalazine. LUT represents luteolin. There were 10, 8, 8, and 9 replicates in NC, MOD, MES, and LUT groups, respectively. **P < 0.01 vs NC group. #P < 0.05 and ##P < 0.01 vs the MOD group.

3.4 Analysis of metabolic profiles of LUT-treated UC rats

To acquire credible and high-quality metabolomic data, the quality control and assurance were performed. The PCA score plots revealed that the samples clustered together (Figure S2a and b), indicating that the data are reliable. Additionally, 82.9% of ions in negative ion mode and 74% of ions in positive ion mode exhibited less than 30% of relative SD, which indicated that the reproducibility of the metabolomics method was excellent. Subsequently, to study the metabolic profiling changes of LUT treatment in UC, PLS-DA was conducted. According to the PLS-DA score plot, the metabolic profiles of the MOD group were far from the NC group (Figure 4). In addition, the metabolic profiles of the LUT group were far from those of the MOD group. Moreover, the metabolic profiles of the LUT group were also far from those of the MES group. These results indicated that metabolites altered between every two of all the groups.

Figure 4 PLS-DA of serum metabolic profiling between normal control (NC), model (MOD), mesalazine (MES), and luteolin (LUT) groups.
Figure 4

PLS-DA of serum metabolic profiling between normal control (NC), model (MOD), mesalazine (MES), and luteolin (LUT) groups.

3.5 Identification of potential metabolites

Differential metabolites were screened based on the standard with VIP > 1 and p < 0.05. We discovered that 102, 74, 118, and 94 metabolites were significantly altered in MOD vs NC, MES vs MOD, LUT vs MOD, and LUT vs MES, respectively (Figure 5a). Interestingly, there were ten common upregulated metabolites and 35 common downregulated metabolites between LUT vs MOD and MES vs MOD (Figure 5b). In addition, a total of 31 differential metabolites were significantly reversed after LUT was used to treat UC in rats (Table S2). In detail, in contrast with the NC group, the levels of 20 metabolites were notably increased in the MOD group, mainly including pimelic acid, deoxyuridine, carnosine, creatinine, phenylacetic acid, gluconic acid, dethiobiotin, indoleglycerol phosphate, isocitric acid, l-glutamine, l-malic acid, and l-lactic acid, and 11 metabolites were notably decreased, mainly including dimethyl sulfone, 5-methylcytosine, cysteine-S-sulfate, homovanillin, arachidic acid, androsterone, and jasmonic acid. However, after LUT treatment, the trend of these metabolites was prominently reversed (Table S2). Similarly, studies have reported that some metabolites such as malic acid, glutamine, lactic acid, and creatinine were associated with the development of UC [23–26]. Therefore, LUT might be involved in the treatment of UC via these metabolites.

Figure 5 Analysis of differential metabolites in serum of UC rats. (a) Number of differential upregulated and downregulated metabolites in MOD vs NC, MES vs MOD, LUT vs MOD, and LUT vs MES. (b) Venn diagram showing common and differential upregulated and downregulated metabolites between LUT vs MOD and MES vs MOD. NC represents normal control. MOD represents model. MES represents mesalazine. LUT represents luteolin.
Figure 5

Analysis of differential metabolites in serum of UC rats. (a) Number of differential upregulated and downregulated metabolites in MOD vs NC, MES vs MOD, LUT vs MOD, and LUT vs MES. (b) Venn diagram showing common and differential upregulated and downregulated metabolites between LUT vs MOD and MES vs MOD. NC represents normal control. MOD represents model. MES represents mesalazine. LUT represents luteolin.

3.6 Metabolic pathway analysis

Metabolic pathway analysis between MOD and LUT groups was carried out according to the KEGG database and MetPA database. The significant metabolic pathways associated with LUT treatment mainly included d-glutamine and d-glutamate metabolism, alanine, aspartate and glutamate metabolism, citrate cycle (TCA cycle), arginine and proline metabolism, glutathione metabolism, pyruvate metabolism, and beta-alanine metabolism (Figure 6; Table S3). Among these pathways, d-glutamine and d-glutamate metabolism, glutathione metabolism, and citrate cycle pathways were associated with the development of UC, which have been reported to be involved in inflammatory response [27–29].

Figure 6 Analysis of metabolic pathway in serum of UC rats treated with LUT. Each point represents one metabolic pathway. The size of the dots indicates the impact on the metabolic pathways.
Figure 6

Analysis of metabolic pathway in serum of UC rats treated with LUT. Each point represents one metabolic pathway. The size of the dots indicates the impact on the metabolic pathways.

4 Discussion

UC is a chronic inflammatory disease characterized by mucosal inflammation, diarrhea, abdominal pain, and hematochezia [30]. Our results demonstrate that levels of TNF-α, CRP, IL-13, IL-33, and ST-2 were prominently elevated in UC rats. However, the opposite results were observed in UC rats treated with LUT. IL-13 is a cytokine which is released by Th2 cells, contributes to the pathology of UC, and participates in immune-mediated processes [31]. IL-33, belonging to the IL-1 cytokine family, exerts a vital role in various inflammatory bowel diseases including UC [32]. A previous study discovered that baicalin can alleviate UC via suppressing the expression of IL-33 [33]. Collectively, these results suggest that LUT alleviates inflammatory response in UC rats.

The imbalance of immune regulation is an important cause of UC [34]. As the central link of immune regulation, T lymphocytes exert a crucial role in the development of UC. Among them, CD4+ T cells and CD8+ T cells are closely relevant to the pathogenesis of UC [35,36]. Extract from mango mistletoes Dendrophthoe pentandra alleviates trinitrobenzene sulfonic acid-induced colitis via modulating CD4+ T cells [37]. The exogenous angiopoietin-like 4 protein can mitigate DSS-induced colitis through reducing CD8+ T cells in the colon [38]. In agreement with these studies, we found that LUT enhanced the ratio of CD4+ T cells and reduced the ratio of CD8+ T cells in UC rats. These findings unveil that CD4+ T cells and CD8+ T cells are crucial in the protective effect of LUT on UC.

Oxidative stress is a key factor in the occurrence of UC. It has been reported that MDA content as indicators of oxidative injury could cause serious cell damage and was enhanced in the colon tissues during UC [39]. SOD as an important endogenous antioxidants protects tissues from damage caused by reactive oxygen species [40]. It was reported that the level of MDA was increased but SOD was decreased in UC mice, while deoxyschizandrin inhibited the effects of DSS on the two levels [41]. A recent study discovered that 5-hydroxy-4-methoxycanthin-6-one reduced the level of MDA and enhanced the levels of SOD in DSS-induced colitic rats [42]. In line with these above studies, our data showed that SOD and T-AOC levels were decreased, while MDA concentration was increased in UC rats. However, their levels were reversed by LUT treatment. These results demonstrate that LUT may inhibit oxidative stress of UC rats and thus reduce the oxidative stress-induced tissues damage.

In this study, to explore the potential therapeutic mechanism of LUT in UC, we focused on the alteration of metabolic profiles in UC rats. We discovered that after DSS treatment in UC rats, amino acid metabolism changed significantly, leading to an upregulation of l-glutamine, and differential metabolites were principally implicated in d-glutamine and d-glutamate metabolism. Studies have reported that glutamine functions in inflammatory response, oxidative stress, cell protection, and intestinal barrier [43–45]. In addition, glutamine supplementation can improve UC [24]. Jeong et al. reported that glutamine exerted anti-inflammatory activity and improved DSS-induced colitis through MKP-1 induction [46]. Ren et al. also found that l-glutamine supplementation had beneficial effects on DSS-induced colitis [47]. Therefore, LUT might ease the inflammation in UC by regulating d-glutamine and d-glutamate metabolism.

Citrate cycle is the most efficient way to acquire energy and offers raw materials for the biosynthesis of numerous important substances [48]. A previous study reported that downregulation of citrate cycle could result in the decrease of energy supply in the colitis [49]. Another study performed metabolomics analysis of UC rats treated with Berberine and found that the metabolites in citrate cycle were remarkably altered by DSS administration and adjusted by Berberine treatment [14]. In our study, citrate cycle was the main metabolic pathway, which was related to LUT treatment. During the citrate cycle, the levels of pyruvic acid and fumaric acid were notably diminished in UC rats after LUT treatment. These data manifest that LUT can regulate the metabolic imbalance in citrate cycle in UC rats.

In conclusion, our study found that LUT attenuated colonic damage, and improved immune response and oxidative stress of UC rats. d-Glutamine and d-glutamate metabolism, glutathione metabolism, and citrate cycle were associated with LUT treating UC. This study offers a basis for further research on the identification of metabolites, pharmacological mechanism, and clinical applications of LUT on UC.

tel: +86-18330182007
tel: +86-13832355120; fax: +86-0311-69095004

Acknowledgements

Not applicable.

  1. Funding information: This study was supported by the Scientific Research Project of Hebei Provincial Administration of Traditional Chinese Medicine on Study on the mechanism of Huazhuo Jiedu traditional Chinese medicine in the treatment of ulcerative colitis based on metabonomics (2020079), Protective effect of Huazhuo Jiedu traditional Chinese medicine on intestinal mucosal epithelial barrier in rats with ulcerative colitis (2020084), and Hebei Provincial “Three Three Three Talents Project” Subsidized Project (C20221097).

  2. Author contributions: Conceptualization and funding acquisition: Qian Yang and Bolin Li. Data curation: Yanru Cai. Investigation: Yuxi Guo and Xuemei Jia. Methodology: Yunfeng Zhang and Xuemei Jia. Writing – original draft: Bolin Li and Yuxi Guo. Writing – review and editing: Bolin Li, Yuxi Guo, Yunfeng Zhang, and Qian Yang. All authors read and approved the final manuscript.

  3. Conflict of interest: The authors have no competing interests to declare that are relevant to the content of this article.

  4. Data availability statement: The data that support the findings of this article are available from the corresponding author upon reasonable request.

References

[1] Neurath M, Leppkes M. Resolution of ulcerative colitis. SemImmunopathology. 2019;41:747–56.10.1007/s00281-019-00751-6Search in Google Scholar PubMed

[2] Ungaro R, Mehandru S, Allen P, Peyrin-Biroulet L, Colombel J. Ulcerative colitis. Lancet (London, Engl). 2017;389:1756–70.10.1016/S0140-6736(16)32126-2Search in Google Scholar PubMed PubMed Central

[3] Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin North Am. 2020;49:643–54.10.1016/j.gtc.2020.07.005Search in Google Scholar PubMed

[4] Kornbluth A, Sachar D. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterology. 2010;105:501–23. quiz 24.10.1038/ajg.2009.727Search in Google Scholar PubMed

[5] Gu S, Xue Y, Gao Y, Shen S, Zhang Y, Chen K, et al. Mechanisms of indigo naturalis on treating ulcerative colitis explored by GEO gene chips combined with network pharmacology and molecular docking. Sci Rep. 2020;10:15204.10.1038/s41598-020-71030-wSearch in Google Scholar PubMed PubMed Central

[6] Dong Y, Xu T, Xiao G, Hu Z, Chen J. Opportunities and challenges for synthetic biology in the therapy of inflammatory bowel disease. Front Bioeng Biotechnol. 2022;10:909591.10.3389/fbioe.2022.909591Search in Google Scholar PubMed PubMed Central

[7] Zang Y, Igarashi K, Li Y. Anti-diabetic effects of luteolin and luteolin-7-O-glucoside on KK-A(y) mice. Biosci Biotechnol Biochem. 2016;80:1580–6.10.1080/09168451.2015.1116928Search in Google Scholar PubMed

[8] Nishitani Y, Yamamoto K, Yoshida M, Azuma T, Kanazawa K, Hashimoto T, et al. Intestinal anti-inflammatory activity of luteolin: role of the aglycone in NF-kappaB inactivation in macrophages co-cultured with intestinal epithelial cells. Biofactors. 2013;39:522–33.10.1002/biof.1091Search in Google Scholar PubMed

[9] Imran M, Rauf A, Abu-Izneid T, Nadeem M, Shariati M, Khan I, et al. Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacother. 2019;112:108612.10.1016/j.biopha.2019.108612Search in Google Scholar PubMed

[10] Liu X, Meng J. Luteolin alleviates LPS-induced bronchopneumonia injury in vitro and in vivo by down-regulating microRNA-132 expression. Biomed Pharmacother. 2018;106:1641–9.10.1016/j.biopha.2018.07.094Search in Google Scholar PubMed

[11] Yu Q, Zhang M, Qian L, Wen D, Wu G. Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway. Life Sci. 2019;225:1–7.10.1016/j.lfs.2019.03.073Search in Google Scholar PubMed

[12] Yang S, Chen P, Chang S, Weng Y, Chang F, Chang K, et al. Luteolin attenuates neutrophilic oxidative stress and inflammatory arthritis by inhibiting Raf1 activity. Biochem Pharmacol. 2018;154:384–96.10.1016/j.bcp.2018.06.003Search in Google Scholar PubMed

[13] Fei J, Liang B, Jiang C, Ni H, Wang L. Luteolin inhibits IL-1β-induced inflammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model. Biomed Pharmacother. 2019;109:1586–92.10.1016/j.biopha.2018.09.161Search in Google Scholar PubMed

[14] Li L, Luo W, Qian Y, Zhu W, Qian J, Li J, et al. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses. Phytomed Int J Phytother Phytopharmacol. 2019;59:152774.10.1016/j.phymed.2018.11.034Search in Google Scholar PubMed

[15] Abu-Elsaad N, El-Karef A. Protection against nonalcoholic steatohepatitis through targeting IL-18 and IL-1alpha by luteolin. Pharmacol Rep: PR. 2019;71:688–94.10.1016/j.pharep.2019.03.009Search in Google Scholar PubMed

[16] Vukelic I, Detel D, Baticic L, Potocnjak I, Domitrovic R. Luteolin ameliorates experimental colitis in mice through ERK-mediated suppression of inflammation, apoptosis and autophagy. Food Chem Toxicol. 2020;145:111680.10.1016/j.fct.2020.111680Search in Google Scholar PubMed

[17] Schicho R, Nazyrova A, Shaykhutdinov R, Duggan G, Vogel H, Storr M. Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by (1)H NMR spectroscopy. J Proteome Res. 2010;9:6265–73.10.1021/pr100547ySearch in Google Scholar PubMed

[18] Zhang Y, Lin L, Xu Y, Lin Y, Jin Y, Zheng C. 1H NMR-based spectroscopy detects metabolic alterations in serum of patients with early-stage ulcerative colitis. Biochem Biophys Res Commun. 2013;433:547–51.10.1016/j.bbrc.2013.03.012Search in Google Scholar PubMed

[19] Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, et al. Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals. Metabolomics. 2015;11:122–33.10.1007/s11306-014-0677-3Search in Google Scholar PubMed PubMed Central

[20] Jia C, Wei Y, Lan Y, Hou X, Zuo J, Wang T, et al. Comprehensive analysis of the metabolomic characteristics on the health lesions induced by chronic arsenic exposure: a metabolomics study. Int J Hyg Environ Health. 2019;222:434–45.10.1016/j.ijheh.2018.12.010Search in Google Scholar PubMed

[21] Liao Z, Zhang S, Liu W, Zou B, Lin L, Chen M, et al. LC-MS-based metabolomics analysis of Berberine treatment in ulcerative colitis rats. J Chromatogr B, Anal Technol Biomed Life Sci. 2019;1133:121848.10.1016/j.jchromb.2019.121848Search in Google Scholar PubMed

[22] Hu L, Wu C, Zhang Z, Liu M, Maruthi Prasad E, Chen Y, et al. Pinocembrin protects against dextran sulfate sodium-induced rats colitis by ameliorating inflammation, improving barrier function and modulating gut microbiota. Front Physiol. 2019;10:908.10.3389/fphys.2019.00908Search in Google Scholar PubMed PubMed Central

[23] Zhou Z, Lin Z, Pang X, Shan P, Wang J. MicroRNA regulation of Toll-like receptor signaling pathways in teleost fish. Fish Shellfish Immunol. 2018;75:32–40.10.1016/j.fsi.2018.01.036Search in Google Scholar PubMed

[24] Wu Q, Liu N, Wu X, Wang G, Lin L. Glutamine alleviates heat stress-induced impairment of intestinal morphology, intestinal inflammatory response, and barrier integrity in broilers. Poult Sci. 2018;97:2675–83.10.3382/ps/pey123Search in Google Scholar PubMed

[25] Abebayehu D, Spence A, Qayum A, Taruselli M, McLeod J, Caslin H, et al. Lactic acid suppresses IL-33-mediated mast cell inflammatory responses via hypoxia-inducible factor-1α-dependent miR-155 suppression. J Immunol (Baltimore, MD: 1950). 2016;197:2909–17.10.4049/jimmunol.1600651Search in Google Scholar PubMed PubMed Central

[26] Riesberg L, McDonald T, Wang Y, Chen X, Holzmer S, Tracy S, et al. Creatinine downregulates TNF-α in macrophage and T cell lines. Cytokine. 2018;110:29–38.10.1016/j.cyto.2018.04.021Search in Google Scholar PubMed

[27] Li Y, Xiao W, Luo W, Zeng C, Deng Z, Ren W, et al. Alterations of amino acid metabolism in osteoarthritis: its implications for nutrition and health. Amino Acids. 2016;48:907–14.10.1007/s00726-015-2168-xSearch in Google Scholar PubMed

[28] Vassilyadi P, Harding S, Nitschmann E, Wykes L. Experimental colitis and malnutrition differentially affect the metabolism of glutathione and related sulfhydryl metabolites in different tissues. Eur J Nutr. 2016;55:1769–76.10.1007/s00394-015-0995-xSearch in Google Scholar PubMed

[29] Liang Q, Wang B, Pang L, Wang Y, Zheng M, Wang Q, et al. Application of citrate as a tricarboxylic acid (TCA) cycle intermediate, prevents diabetic-induced heart damages in mice. Iran J Basic Med Sci. 2016;19:43–8.Search in Google Scholar

[30] Bopanna S, Ananthakrishnan A, Kedia S, Yajnik V, Ahuja V. Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2:269–76.10.1016/S2468-1253(17)30004-3Search in Google Scholar PubMed PubMed Central

[31] Krug SM, Bojarski C, Fromm A, Lee IM, Dames P, Richter JF, et al. Tricellulin is regulated via interleukin-13-receptor alpha2, affects macromolecule uptake, and is decreased in ulcerative colitis. Mucosal Immunol. 2018;11:345–56.10.1038/mi.2017.52Search in Google Scholar PubMed PubMed Central

[32] Kobori A, Yagi Y, Imaeda H, Ban H, Bamba S, Tsujikawa T, et al. Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol. 2010;45:999–1007.10.1007/s00535-010-0245-1Search in Google Scholar PubMed

[33] Zhang CL, Zhang S, He WX, Lu JL, Xu YJ, Yang JY, et al. Baicalin may alleviate inflammatory infiltration in dextran sodium sulfate-induced chronic ulcerative colitis via inhibiting IL-33 expression. Life Sci. 2017;186:125–32.10.1016/j.lfs.2017.08.010Search in Google Scholar PubMed

[34] Nakase H, Sato N, Mizuno N, Ikawa Y. The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmun Rev. 2022;21:103017.10.1016/j.autrev.2021.103017Search in Google Scholar PubMed

[35] Corridoni D, Antanaviciute A, Gupta T, Fawkner-Corbett D, Aulicino A, Jagielowicz M, et al. Single-cell atlas of colonic CD8(+) T cells in ulcerative colitis. Nat Med. 2020;26:1480–90.10.1038/s41591-020-1003-4Search in Google Scholar PubMed

[36] Dou D, Ji Y, Zheng J, Li J, Zhu X, Tang S, et al. A new role for conivaptan in ulcerative colitis in mice: inhibiting differentiation of CD4(+)T cells into Th1 cells. Dig Dis Sci. 2022;67:3683–92.10.1007/s10620-021-07300-ySearch in Google Scholar PubMed

[37] Endharti AT, Permana S. Extract from mango mistletoes Dendrophthoe pentandra ameliorates TNBS-induced colitis by regulating CD4 + T cells in mesenteric lymph nodes. BMC Complement Altern Med. 2017;17:468.10.1186/s12906-017-1973-zSearch in Google Scholar PubMed PubMed Central

[38] Zhang X, Tu J, Ding S, Wang M, Ding Y, Lin Z, et al. Increased angiopoietin-like 4 expression ameliorates inflammatory bowel diseases via suppressing CD8(+) T cell activities. Biochem Biophys Res Commun. 2022;612:37–43.10.1016/j.bbrc.2022.03.153Search in Google Scholar PubMed

[39] Amirshahrokhi K. Febuxostat attenuates ulcerative colitis by the inhibition of NF-kappaB, proinflammatory cytokines, and oxidative stress in mice. Int Immunopharmacol. 2019;76:105884.10.1016/j.intimp.2019.105884Search in Google Scholar PubMed

[40] Ballal SA, Veiga P, Fenn K, Michaud M, Kim JH, Gallini CA, et al. Host lysozyme-mediated lysis of Lactococcus lactis facilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons. Proc Natl Acad Sci USA. 2015;112:7803–8.10.1073/pnas.1501897112Search in Google Scholar PubMed PubMed Central

[41] Yu S, Qian H. Deoxyschizandrin treats mice with ulcerative colitis possibly via the TLR4/NF-kappaB signaling pathway. Am J Transl Res. 2021;13:3856–63.Search in Google Scholar

[42] Liu F, Yao Y, Lu Z, Zhang Q, Liu C, Zhu C, et al. 5-Hydroxy-4-methoxycanthin-6-one alleviates dextran sodium sulfate-induced colitis in rats via regulation of metabolic profiling and suppression of NF-kappaB/p65 signaling pathway. Phytomedicine. 2021;82:153438.10.1016/j.phymed.2020.153438Search in Google Scholar PubMed

[43] Crespo I, San-Miguel B, Prause C, Marroni N, Cuevas M, González-Gallego J, et al. Glutamine treatment attenuates endoplasmic reticulum stress and apoptosis in TNBS-induced colitis. PLoS One. 2012;7:e50407.10.1371/journal.pone.0050407Search in Google Scholar PubMed PubMed Central

[44] Fillmann H, Kretzmann N, San-Miguel B, Llesuy S, Marroni N, González-Gallego J, et al. Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat. Toxicology. 2007;236:217–26.10.1016/j.tox.2007.04.012Search in Google Scholar PubMed

[45] Vicario M, Amat C, Rivero M, Moretó M, Pelegrí C. Dietary glutamine affects mucosal functions in rats with mild DSS-induced colitis. J Nutr. 2007;137:1931–7.10.1093/jn/137.8.1931Search in Google Scholar PubMed

[46] Jeong S, Im Y, Youm J, Lee H, Im S. l-Glutamine attenuates DSS-induced colitis via induction of MAPK phosphatase-1. Nutrients. 2018;10:288.10.3390/nu10030288Search in Google Scholar PubMed PubMed Central

[47] Ren W, Yin J, Wu M, Liu G, Yang G, Xion Y, et al. Serum amino acids profile and the beneficial effects of l-arginine or l-glutamine supplementation in dextran sulfate sodium colitis. PLoS One. 2014;9:e88335.10.1371/journal.pone.0088335Search in Google Scholar PubMed PubMed Central

[48] Patil N, Bohannon J, Hernandez A, Patil T, Sherwood E. Regulation of leukocyte function by citric acid cycle intermediates. J Leukoc Biol. 2019;106:105–17.10.1002/JLB.3MIR1118-415RSearch in Google Scholar PubMed PubMed Central

[49] Ooi M, Nishiumi S, Yoshie T, Shiomi Y, Kohashi M, Fukunaga K, et al. GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis. Inflamm Res: Off J Eur Histamine Res Soc [et al]. 2011;60:831–40.10.1007/s00011-011-0340-7Search in Google Scholar PubMed

Received: 2023-01-17
Revised: 2023-05-30
Accepted: 2023-08-04
Published Online: 2023-08-30

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. Exosomes derived from mesenchymal stem cells overexpressing miR-210 inhibits neuronal inflammation and contribute to neurite outgrowth through modulating microglia polarization
  3. Current situation of acute ST-segment elevation myocardial infarction in a county hospital chest pain center during an epidemic of novel coronavirus pneumonia
  4. circ-IARS depletion inhibits the progression of non-small-cell lung cancer by circ-IARS/miR-1252-5p/HDGF ceRNA pathway
  5. circRNA ITGA7 restrains growth and enhances radiosensitivity by up-regulating SMAD4 in colorectal carcinoma
  6. WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4
  7. Up-regulation of collagen type V alpha 2 (COL5A2) promotes malignant phenotypes in gastric cancer cell via inducing epithelial–mesenchymal transition (EMT)
  8. Inhibition of TERC inhibits neural apoptosis and inflammation in spinal cord injury through Akt activation and p-38 inhibition via the miR-34a-5p/XBP-1 axis
  9. 3D-printed polyether-ether-ketone/n-TiO2 composite enhances the cytocompatibility and osteogenic differentiation of MC3T3-E1 cells by downregulating miR-154-5p
  10. Propofol-mediated circ_0000735 downregulation restrains tumor growth by decreasing integrin-β1 expression in non-small cell lung cancer
  11. PVT1/miR-16/CCND1 axis regulates gastric cancer progression
  12. Silencing of circ_002136 sensitizes gastric cancer to paclitaxel by targeting the miR-16-5p/HMGA1 axis
  13. Short-term outcomes after simultaneous gastrectomy plus cholecystectomy in gastric cancer: A pooling up analysis
  14. SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways
  15. Molecular mechanism by which the Notch signaling pathway regulates autophagy in a rat model of pulmonary fibrosis in pigeon breeder’s lung
  16. lncRNA TPT1-AS1 promotes cell migration and invasion in esophageal squamous-cell carcinomas by regulating the miR-26a/HMGA1 axis
  17. SIRT1/APE1 promotes the viability of gastric cancer cells by inhibiting p53 to suppress ferroptosis
  18. Glycoprotein non-metastatic melanoma B interacts with epidermal growth factor receptor to regulate neural stem cell survival and differentiation
  19. Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
  20. Association of osteoporosis and skeletal muscle loss with serum type I collagen carboxyl-terminal peptide β glypeptide: A cross-sectional study in elder Chinese population
  21. circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathway
  22. Delivery in a vertical birth chair supported by freedom of movement during labor: A randomized control trial
  23. UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K/AKT and MDM2/p53 signaling
  24. Metabolic resuscitation therapy in critically ill patients with sepsis and septic shock: A pilot prospective randomized controlled trial
  25. Lycopene ameliorates locomotor activity and urinary frequency induced by pelvic venous congestion in rats
  26. UHRF1-induced connexin26 methylation is involved in hearing damage triggered by intermittent hypoxia in neonatal rats
  27. LINC00511 promotes melanoma progression by targeting miR-610/NUCB2
  28. Ultra-high-performance liquid chromatography-tandem mass spectrometry analysis of serum metabolomic characteristics in people with different vitamin D levels
  29. Role of Jumonji domain-containing protein D3 and its inhibitor GSK-J4 in Hashimoto’s thyroiditis
  30. circ_0014736 induces GPR4 to regulate the biological behaviors of human placental trophoblast cells through miR-942-5p in preeclampsia
  31. Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies
  32. Effects of osteogenic growth peptide C-terminal pentapeptide and its analogue on bone remodeling in an osteoporosis rat model
  33. A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma
  34. WGCNA-based identification of potential targets and pathways in response to treatment in locally advanced breast cancer patients
  35. Radiomics model using preoperative computed tomography angiography images to differentiate new from old emboli of acute lower limb arterial embolism
  36. Dysregulated lncRNAs are involved in the progress of myocardial infarction by constructing regulatory networks
  37. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy
  38. Genetic polymorphisms of MRPS30-DT and NINJ2 may influence lung cancer risk
  39. Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis
  40. Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma
  41. Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
  42. CircRANBP17 modulated KDM1A to regulate neuroblastoma progression by sponging miR-27b-3p
  43. Exosomal miR-93-5p regulated the progression of osteoarthritis by targeting ADAMTS9
  44. Downregulation of RBM17 enhances cisplatin sensitivity and inhibits cell invasion in human hypopharyngeal cancer cells
  45. HDAC5-mediated PRAME regulates the proliferation, migration, invasion, and EMT of laryngeal squamous cell carcinoma via the PI3K/AKT/mTOR signaling pathway
  46. The association between sleep duration, quality, and nonalcoholic fatty liver disease: A cross-sectional study
  47. Myostatin silencing inhibits podocyte apoptosis in membranous nephropathy through Smad3/PKA/NOX4 signaling pathway
  48. A novel long noncoding RNA AC125257.1 facilitates colorectal cancer progression by targeting miR-133a-3p/CASC5 axis
  49. Impact of omicron wave and associated control measures in Shanghai on health management and psychosocial well-being of patients with chronic conditions
  50. Clinicopathological characteristics and prognosis of young patients aged ≤45 years old with non-small cell lung cancer
  51. TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia
  52. The dose limits of teeth protection for patients with nasopharyngeal carcinoma undergoing radiotherapy based on the early oral health-related quality of life
  53. miR-30b-5p targeting GRIN2A inhibits hippocampal damage in epilepsy
  54. Long non-coding RNA AL137789.1 promoted malignant biological behaviors and immune escape of pancreatic carcinoma cells
  55. IRF6 and FGF1 polymorphisms in non-syndromic cleft lip with or without cleft palate in the Polish population
  56. Comprehensive analysis of the role of SFXN family in breast cancer
  57. Efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in lung squamous cell carcinoma patients underwent conventional chemoradiotherapy
  58. Silencing of long noncoding RNA MIAT inhibits the viability and proliferation of breast cancer cells by promoting miR-378a-5p expression
  59. AG1024, an IGF-1 receptor inhibitor, ameliorates renal injury in rats with diabetic nephropathy via the SOCS/JAK2/STAT pathway
  60. Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition
  61. Exendin-4 regulates the MAPK and WNT signaling pathways to alleviate the osteogenic inhibition of periodontal ligament stem cells in a high glucose environment
  62. Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3
  63. The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma
  64. Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
  65. Ultrasound examination supporting CT or MRI in the evaluation of cervical lymphadenopathy in patients with irradiation-treated head and neck cancer
  66. F-box and WD repeat domain containing 7 inhibits the activation of hepatic stellate cells by degrading delta-like ligand 1 to block Notch signaling pathway
  67. Knockdown of circ_0005615 enhances the radiosensitivity of colorectal cancer by regulating the miR-665/NOTCH1 axis
  68. Long noncoding RNA Mhrt alleviates angiotensin II-induced cardiac hypertrophy phenotypes by mediating the miR-765/Wnt family member 7B pathway
  69. Effect of miR-499-5p/SOX6 axis on atrial fibrosis in rats with atrial fibrillation
  70. Cholesterol induces inflammation and reduces glucose utilization
  71. circ_0004904 regulates the trophoblast cell in preeclampsia via miR-19b-3p/ARRDC3 axis
  72. NECAB3 promotes the migration and invasion of liver cancer cells through HIF-1α/RIT1 signaling pathway
  73. The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
  74. miR-2053 inhibits the growth of ovarian cancer cells by downregulating SOX4
  75. Nucleophosmin 1 associating with engulfment and cell motility protein 1 regulates hepatocellular carcinoma cell chemotaxis and metastasis
  76. α-Hederin regulates macrophage polarization to relieve sepsis-induced lung and liver injuries in mice
  77. Changes of microbiota level in urinary tract infections: A meta-analysis
  78. Identification of key enzalutamide-resistance-related genes in castration-resistant prostate cancer and verification of RAD51 functions
  79. Falls during oxaliplatin-based chemotherapy for gastrointestinal malignancies – (lessons learned from) a prospective study
  80. Outcomes of low-risk birth care during the Covid-19 pandemic: A cohort study from a tertiary care center in Lithuania
  81. Vitamin D protects intestines from liver cirrhosis-induced inflammation and oxidative stress by inhibiting the TLR4/MyD88/NF-κB signaling pathway
  82. Integrated transcriptome analysis identifies APPL1/RPS6KB2/GALK1 as immune-related metastasis factors in breast cancer
  83. Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
  84. Circular RNA Circ_0038467 promotes the maturation of miRNA-203 to increase lipopolysaccharide-induced apoptosis of chondrocytes
  85. An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy
  86. Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
  87. Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
  88. PTPN12 down-regulated by miR-146b-3p gene affects the malignant progression of laryngeal squamous cell carcinoma
  89. miR-141-3p accelerates ovarian cancer progression and promotes M2-like macrophage polarization by targeting the Keap1-Nrf2 pathway
  90. lncRNA OIP5-AS1 attenuates the osteoarthritis progression in IL-1β-stimulated chondrocytes
  91. Overexpression of LINC00607 inhibits cell growth and aggressiveness by regulating the miR-1289/EFNA5 axis in non-small-cell lung cancer
  92. Subjective well-being in informal caregivers during the COVID-19 pandemic
  93. Nrf2 protects against myocardial ischemia-reperfusion injury in diabetic rats by inhibiting Drp1-mediated mitochondrial fission
  94. Unfolded protein response inhibits KAT2B/MLKL-mediated necroptosis of hepatocytes by promoting BMI1 level to ubiquitinate KAT2B
  95. Bladder cancer screening: The new selection and prediction model
  96. circNFATC3 facilitated the progression of oral squamous cell carcinoma via the miR-520h/LDHA axis
  97. Prone position effect in intensive care patients with SARS-COV-2 pneumonia
  98. Clinical observation on the efficacy of Tongdu Tuina manipulation in the treatment of primary enuresis in children
  99. Dihydroartemisinin ameliorates cerebral I/R injury in rats via regulating VWF and autophagy-mediated SIRT1/FOXO1 pathway
  100. Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway
  101. Low Ang-(1–7) and high des-Arg9 bradykinin serum levels are correlated with cardiovascular risk factors in patients with COVID-19
  102. Effect of maternal age and body mass index on induction of labor with oral misoprostol for premature rupture of membrane at term: A retrospective cross-sectional study
  103. Potential protective effects of Huanglian Jiedu Decoction against COVID-19-associated acute kidney injury: A network-based pharmacological and molecular docking study
  104. Clinical significance of serum MBD3 detection in girls with central precocious puberty
  105. Clinical features of varicella-zoster virus caused neurological diseases detected by metagenomic next-generation sequencing
  106. Collagen treatment of complex anorectal fistula: 3 years follow-up
  107. LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through down-regulating SP-A by sponging to miR-424
  108. Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen – An open-label, randomized trial
  109. SMOC2 plays a role in heart failure via regulating TGF-β1/Smad3 pathway-mediated autophagy
  110. A prospective cohort study of the impact of chronic disease on fall injuries in middle-aged and older adults
  111. circRNA THBS1 silencing inhibits the malignant biological behavior of cervical cancer cells via the regulation of miR-543/HMGB2 axis
  112. hsa_circ_0000285 sponging miR-582-3p promotes neuroblastoma progression by regulating the Wnt/β-catenin signaling pathway
  113. Long non-coding RNA GNAS-AS1 knockdown inhibits proliferation and epithelial–mesenchymal transition of lung adenocarcinoma cells via the microRNA-433-3p/Rab3A axis
  114. lncRNA UCA1 regulates miR-132/Lrrfip1 axis to promote vascular smooth muscle cell proliferation
  115. Twenty-four-color full spectrum flow cytometry panel for minimal residual disease detection in acute myeloid leukemia
  116. Hsa-miR-223-3p participates in the process of anthracycline-induced cardiomyocyte damage by regulating NFIA gene
  117. Anti-inflammatory effect of ApoE23 on Salmonella typhimurium-induced sepsis in mice
  118. Analysis of somatic mutations and key driving factors of cervical cancer progression
  119. Hsa_circ_0028007 regulates the progression of nasopharyngeal carcinoma through the miR-1179/SQLE axis
  120. Variations in sexual function after laparoendoscopic single-site hysterectomy in women with benign gynecologic diseases
  121. Effects of pharmacological delay with roxadustat on multi-territory perforator flap survival in rats
  122. Analysis of heroin effects on calcium channels in rat cardiomyocytes based on transcriptomics and metabolomics
  123. Risk factors of recurrent bacterial vaginosis among women of reproductive age: A cross-sectional study
  124. Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells
  125. Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients
  126. Correlation between microvessel maturity and ISUP grades assessed using contrast-enhanced transrectal ultrasonography in prostate cancer
  127. The protective effect of caffeic acid phenethyl ester in the nephrotoxicity induced by α-cypermethrin
  128. Norepinephrine alleviates cyclosporin A-induced nephrotoxicity by enhancing the expression of SFRP1
  129. Effect of RUNX1/FOXP3 axis on apoptosis of T and B lymphocytes and immunosuppression in sepsis
  130. The function of Foxp1 represses β-adrenergic receptor transcription in the occurrence and development of bladder cancer through STAT3 activity
  131. Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU
  132. Calycosin protects against chronic prostatitis in rats via inhibition of the p38MAPK/NF-κB pathway
  133. Pan-cancer analysis of the PDE4DIP gene with potential prognostic and immunotherapeutic values in multiple cancers including acute myeloid leukemia
  134. The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
  135. Circ-UBR4 regulates the proliferation, migration, inflammation, and apoptosis in ox-LDL-induced vascular smooth muscle cells via miR-515-5p/IGF2 axis
  136. Clinical characteristics of current COVID-19 rehabilitation outpatients in China
  137. Luteolin alleviates ulcerative colitis in rats via regulating immune response, oxidative stress, and metabolic profiling
  138. miR-199a-5p inhibits aortic valve calcification by targeting ATF6 and GRP78 in valve interstitial cells
  139. The application of iliac fascia space block combined with esketamine intravenous general anesthesia in PFNA surgery of the elderly: A prospective, single-center, controlled trial
  140. Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
  141. The effects of progesterone on the healing of obstetric anal sphincter damage in female rats
  142. Identification of cuproptosis-related genes for predicting the development of prostate cancer
  143. Lumican silencing ameliorates β-glycerophosphate-mediated vascular smooth muscle cell calcification by attenuating the inhibition of APOB on KIF2C activity
  144. Targeting PTBP1 blocks glutamine metabolism to improve the cisplatin sensitivity of hepatocarcinoma cells through modulating the mRNA stability of glutaminase
  145. A single center prospective study: Influences of different hip flexion angles on the measurement of lumbar spine bone mineral density by dual energy X-ray absorptiometry
  146. Clinical analysis of AN69ST membrane continuous venous hemofiltration in the treatment of severe sepsis
  147. Antibiotics therapy combined with probiotics administered intravaginally for the treatment of bacterial vaginosis: A systematic review and meta-analysis
  148. Construction of a ceRNA network to reveal a vascular invasion associated prognostic model in hepatocellular carcinoma
  149. A pan-cancer analysis of STAT3 expression and genetic alterations in human tumors
  150. A prognostic signature based on seven T-cell-related cell clustering genes in bladder urothelial carcinoma
  151. Pepsin concentration in oral lavage fluid of rabbit reflux model constructed by dilating the lower esophageal sphincter
  152. The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
  153. Tanshinone IIA attenuates valvular interstitial cells’ calcification induced by oxidized low density lipoprotein via reducing endoplasmic reticulum stress
  154. AS-IV enhances the antitumor effects of propofol in NSCLC cells by inhibiting autophagy
  155. Establishment of two oxaliplatin-resistant gallbladder cancer cell lines and comprehensive analysis of dysregulated genes
  156. Trial protocol: Feasibility of neuromodulation with connectivity-guided intermittent theta-burst stimulation for improving cognition in multiple sclerosis
  157. LncRNA LINC00592 mediates the promoter methylation of WIF1 to promote the development of bladder cancer
  158. Factors associated with gastrointestinal dysmotility in critically ill patients
  159. Mechanisms by which spinal cord stimulation intervenes in atrial fibrillation: The involvement of the endothelin-1 and nerve growth factor/p75NTR pathways
  160. Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics
  161. Silencing USP19 alleviates cigarette smoke extract-induced mitochondrial dysfunction in BEAS-2B cells by targeting FUNDC1
  162. Menstrual irregularities associated with COVID-19 vaccines among women in Saudi Arabia: A survey during 2022
  163. Ferroptosis involves in Schwann cell death in diabetic peripheral neuropathy
  164. The effect of AQP4 on tau protein aggregation in neurodegeneration and persistent neuroinflammation after cerebral microinfarcts
  165. Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
  166. Analysis of clinical characteristics in proximal and distal reflux monitoring among patients with gastroesophageal reflux disease
  167. Exosomal circ-0020887 and circ-0009590 as novel biomarkers for the diagnosis and prediction of short-term adverse cardiovascular outcomes in STEMI patients
  168. Upregulated microRNA-429 confers endometrial stromal cell dysfunction by targeting HIF1AN and regulating the HIF1A/VEGF pathway
  169. Bibliometrics and knowledge map analysis of ultrasound-guided regional anesthesia
  170. Knockdown of NUPR1 inhibits angiogenesis in lung cancer through IRE1/XBP1 and PERK/eIF2α/ATF4 signaling pathways
  171. D-dimer trends predict COVID-19 patient’s prognosis: A retrospective chart review study
  172. WTAP affects intracranial aneurysm progression by regulating m6A methylation modification
  173. Using of endoscopic polypectomy in patients with diagnosed malignant colorectal polyp – The cross-sectional clinical study
  174. Anti-S100A4 antibody administration alleviates bronchial epithelial–mesenchymal transition in asthmatic mice
  175. Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma
  176. Prevalence and antibiogram of bacteria causing urinary tract infection among patients with chronic kidney disease
  177. Reactive oxygen species within the vaginal space: An additional promoter of cervical intraepithelial neoplasia and uterine cervical cancer development?
  178. Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma
  179. A new technique for uterine-preserving pelvic organ prolapse surgery: Laparoscopic rectus abdominis hysteropexy for uterine prolapse by comparing with traditional techniques
  180. Self-isolation of an Italian long-term care facility during COVID-19 pandemic: A comparison study on care-related infectious episodes
  181. A comparative study on the overlapping effects of clinically applicable therapeutic interventions in patients with central nervous system damage
  182. Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome: Long-term follow-up
  183. The diagnostic accuracy of touch imprint cytology for sentinel lymph node metastases of breast cancer: An up-to-date meta-analysis of 4,073 patients
  184. Mortality associated with Sjögren’s syndrome in the United States in the 1999–2020 period: A multiple cause-of-death study
  185. CircMMP11 as a prognostic biomarker mediates miR-361-3p/HMGB1 axis to accelerate malignant progression of hepatocellular carcinoma
  186. Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations
  187. KMT2A maintains stemness of gastric cancer cells through regulating Wnt/β-catenin signaling-activated transcriptional factor KLF11
  188. Evaluation of placental oxygenation by near-infrared spectroscopy in relation to ultrasound maturation grade in physiological term pregnancies
  189. The role of ultrasonographic findings for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer
  190. Construction of immunogenic cell death-related molecular subtypes and prognostic signature in colorectal cancer
  191. Long-term prognostic value of high-sensitivity cardiac troponin-I in patients with idiopathic dilated cardiomyopathy
  192. Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients
  193. Integrative bioinformatics analysis reveals STAT2 as a novel biomarker of inflammation-related cardiac dysfunction in atrial fibrillation
  194. Adipose-derived stem cells repair radiation-induced chronic lung injury via inhibiting TGF-β1/Smad 3 signaling pathway
  195. Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000–2016 cohort
  196. lncRNA LENGA sponges miR-378 to promote myocardial fibrosis in atrial fibrillation
  197. Diagnostic value of urinary Tamm-Horsfall protein and 24 h urine osmolality for recurrent calcium oxalate stones of the upper urinary tract: Cross-sectional study
  198. The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer
  199. The spike protein of SARS-CoV-2 induces inflammation and EMT of lung epithelial cells and fibroblasts through the upregulation of GADD45A
  200. Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
  201. MiR-1278 targets CALD1 and suppresses the progression of gastric cancer via the MAPK pathway
  202. Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson’s disease after dietary supplementation with branched-chain amino acids
  203. Cimifugin inhibits adipogenesis and TNF-α-induced insulin resistance in 3T3-L1 cells
  204. Predictors of gastrointestinal complaints in patients on metformin therapy
  205. Prescribing patterns in patients with chronic obstructive pulmonary disease and atrial fibrillation
  206. A retrospective analysis of the effect of latent tuberculosis infection on clinical pregnancy outcomes of in vitro fertilization–fresh embryo transferred in infertile women
  207. Appropriateness and clinical outcomes of short sustained low-efficiency dialysis: A national experience
  208. miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD
  209. Clinical features and management of lymphoepithelial cyst
  210. Serum VEGF, high-sensitivity CRP, and cystatin-C assist in the diagnosis of type 2 diabetic retinopathy complicated with hyperuricemia
  211. ENPP1 ameliorates vascular calcification via inhibiting the osteogenic transformation of VSMCs and generating PPi
  212. Significance of monitoring the levels of thyroid hormone antibodies and glucose and lipid metabolism antibodies in patients suffer from type 2 diabetes
  213. The causal relationship between immune cells and different kidney diseases: A Mendelian randomization study
  214. Interleukin 33, soluble suppression of tumorigenicity 2, interleukin 27, and galectin 3 as predictors for outcome in patients admitted to intensive care units
  215. Identification of diagnostic immune-related gene biomarkers for predicting heart failure after acute myocardial infarction
  216. Long-term administration of probiotics prevents gastrointestinal mucosal barrier dysfunction in septic mice partly by upregulating the 5-HT degradation pathway
  217. miR-192 inhibits the activation of hepatic stellate cells by targeting Rictor
  218. Diagnostic and prognostic value of MR-pro ADM, procalcitonin, and copeptin in sepsis
  219. Review Articles
  220. Prenatal diagnosis of fetal defects and its implications on the delivery mode
  221. Electromagnetic fields exposure on fetal and childhood abnormalities: Systematic review and meta-analysis
  222. Characteristics of antibiotic resistance mechanisms and genes of Klebsiella pneumoniae
  223. Saddle pulmonary embolism in the setting of COVID-19 infection: A systematic review of case reports and case series
  224. Vitamin C and epigenetics: A short physiological overview
  225. Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients
  226. Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
  227. Mechanism of rhubarb in the treatment of hyperlipidemia: A recent review
  228. Surgical management and outcomes of traumatic global brachial plexus injury: A concise review and our center approach
  229. The progress of autoimmune hepatitis research and future challenges
  230. METTL16 in human diseases: What should we do next?
  231. New insights into the prevention of ureteral stents encrustation
  232. VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature
  233. Case Reports
  234. Mycobacterium xenopi infection of the kidney and lymph nodes: A case report
  235. Genetic mutation of SLC6A20 (c.1072T > C) in a family with nephrolithiasis: A case report
  236. Chronic hepatitis B complicated with secondary hemochromatosis was cured clinically: A case report
  237. Liver abscess complicated with multiple organ invasive infection caused by hematogenous disseminated hypervirulent Klebsiella pneumoniae: A case report
  238. Urokinase-based lock solutions for catheter salvage: A case of an upcoming kidney transplant recipient
  239. Two case reports of maturity-onset diabetes of the young type 3 caused by the hepatocyte nuclear factor 1α gene mutation
  240. Immune checkpoint inhibitor-related pancreatitis: What is known and what is not
  241. Does total hip arthroplasty result in intercostal nerve injury? A case report and literature review
  242. Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi – Case report and literature review
  243. Synchronous triple primary gastrointestinal malignant tumors treated with laparoscopic surgery: A case report
  244. CT-guided percutaneous microwave ablation combined with bone cement injection for the treatment of transverse metastases: A case report
  245. Malignant hyperthermia: Report on a successful rescue of a case with the highest temperature of 44.2°C
  246. Anesthetic management of fetal pulmonary valvuloplasty: A case report
  247. Rapid Communication
  248. Impact of COVID-19 lockdown on glycemic levels during pregnancy: A retrospective analysis
  249. Erratum
  250. Erratum to “Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway”
  251. Erratum to: “Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p”
  252. Retraction
  253. Retraction of “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients”
  254. Retraction of “circ_0062491 alleviates periodontitis via the miR-142-5p/IGF1 axis”
  255. Retraction of “miR-223-3p alleviates TGF-β-induced epithelial-mesenchymal transition and extracellular matrix deposition by targeting SP3 in endometrial epithelial cells”
  256. Retraction of “SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis”
  257. Retraction of “circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury”
  258. Retraction of “lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells”
  259. Special issue Linking Pathobiological Mechanisms to Clinical Application for cardiovascular diseases
  260. Effect of cardiac rehabilitation therapy on depressed patients with cardiac insufficiency after cardiac surgery
  261. Special issue The evolving saga of RNAs from bench to bedside - Part I
  262. FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma
  263. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part III
  264. Development of a machine learning-based signature utilizing inflammatory response genes for predicting prognosis and immune microenvironment in ovarian cancer
https://doi.org/10.1515/med-2023-0785
Keywords for this article
ulcerative colitis; luteolin; oxidative stress; immune response; metabolomics; liquid chromatography-mass spectrometry
Creative Commons
BY 4.0

Articles in the same Issue

  1. Research Articles
  2. Exosomes derived from mesenchymal stem cells overexpressing miR-210 inhibits neuronal inflammation and contribute to neurite outgrowth through modulating microglia polarization
  3. Current situation of acute ST-segment elevation myocardial infarction in a county hospital chest pain center during an epidemic of novel coronavirus pneumonia
  4. circ-IARS depletion inhibits the progression of non-small-cell lung cancer by circ-IARS/miR-1252-5p/HDGF ceRNA pathway
  5. circRNA ITGA7 restrains growth and enhances radiosensitivity by up-regulating SMAD4 in colorectal carcinoma
  6. WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4
  7. Up-regulation of collagen type V alpha 2 (COL5A2) promotes malignant phenotypes in gastric cancer cell via inducing epithelial–mesenchymal transition (EMT)
  8. Inhibition of TERC inhibits neural apoptosis and inflammation in spinal cord injury through Akt activation and p-38 inhibition via the miR-34a-5p/XBP-1 axis
  9. 3D-printed polyether-ether-ketone/n-TiO2 composite enhances the cytocompatibility and osteogenic differentiation of MC3T3-E1 cells by downregulating miR-154-5p
  10. Propofol-mediated circ_0000735 downregulation restrains tumor growth by decreasing integrin-β1 expression in non-small cell lung cancer
  11. PVT1/miR-16/CCND1 axis regulates gastric cancer progression
  12. Silencing of circ_002136 sensitizes gastric cancer to paclitaxel by targeting the miR-16-5p/HMGA1 axis
  13. Short-term outcomes after simultaneous gastrectomy plus cholecystectomy in gastric cancer: A pooling up analysis
  14. SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways
  15. Molecular mechanism by which the Notch signaling pathway regulates autophagy in a rat model of pulmonary fibrosis in pigeon breeder’s lung
  16. lncRNA TPT1-AS1 promotes cell migration and invasion in esophageal squamous-cell carcinomas by regulating the miR-26a/HMGA1 axis
  17. SIRT1/APE1 promotes the viability of gastric cancer cells by inhibiting p53 to suppress ferroptosis
  18. Glycoprotein non-metastatic melanoma B interacts with epidermal growth factor receptor to regulate neural stem cell survival and differentiation
  19. Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
  20. Association of osteoporosis and skeletal muscle loss with serum type I collagen carboxyl-terminal peptide β glypeptide: A cross-sectional study in elder Chinese population
  21. circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathway
  22. Delivery in a vertical birth chair supported by freedom of movement during labor: A randomized control trial
  23. UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K/AKT and MDM2/p53 signaling
  24. Metabolic resuscitation therapy in critically ill patients with sepsis and septic shock: A pilot prospective randomized controlled trial
  25. Lycopene ameliorates locomotor activity and urinary frequency induced by pelvic venous congestion in rats
  26. UHRF1-induced connexin26 methylation is involved in hearing damage triggered by intermittent hypoxia in neonatal rats
  27. LINC00511 promotes melanoma progression by targeting miR-610/NUCB2
  28. Ultra-high-performance liquid chromatography-tandem mass spectrometry analysis of serum metabolomic characteristics in people with different vitamin D levels
  29. Role of Jumonji domain-containing protein D3 and its inhibitor GSK-J4 in Hashimoto’s thyroiditis
  30. circ_0014736 induces GPR4 to regulate the biological behaviors of human placental trophoblast cells through miR-942-5p in preeclampsia
  31. Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies
  32. Effects of osteogenic growth peptide C-terminal pentapeptide and its analogue on bone remodeling in an osteoporosis rat model
  33. A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma
  34. WGCNA-based identification of potential targets and pathways in response to treatment in locally advanced breast cancer patients
  35. Radiomics model using preoperative computed tomography angiography images to differentiate new from old emboli of acute lower limb arterial embolism
  36. Dysregulated lncRNAs are involved in the progress of myocardial infarction by constructing regulatory networks
  37. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy
  38. Genetic polymorphisms of MRPS30-DT and NINJ2 may influence lung cancer risk
  39. Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis
  40. Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma
  41. Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
  42. CircRANBP17 modulated KDM1A to regulate neuroblastoma progression by sponging miR-27b-3p
  43. Exosomal miR-93-5p regulated the progression of osteoarthritis by targeting ADAMTS9
  44. Downregulation of RBM17 enhances cisplatin sensitivity and inhibits cell invasion in human hypopharyngeal cancer cells
  45. HDAC5-mediated PRAME regulates the proliferation, migration, invasion, and EMT of laryngeal squamous cell carcinoma via the PI3K/AKT/mTOR signaling pathway
  46. The association between sleep duration, quality, and nonalcoholic fatty liver disease: A cross-sectional study
  47. Myostatin silencing inhibits podocyte apoptosis in membranous nephropathy through Smad3/PKA/NOX4 signaling pathway
  48. A novel long noncoding RNA AC125257.1 facilitates colorectal cancer progression by targeting miR-133a-3p/CASC5 axis
  49. Impact of omicron wave and associated control measures in Shanghai on health management and psychosocial well-being of patients with chronic conditions
  50. Clinicopathological characteristics and prognosis of young patients aged ≤45 years old with non-small cell lung cancer
  51. TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia
  52. The dose limits of teeth protection for patients with nasopharyngeal carcinoma undergoing radiotherapy based on the early oral health-related quality of life
  53. miR-30b-5p targeting GRIN2A inhibits hippocampal damage in epilepsy
  54. Long non-coding RNA AL137789.1 promoted malignant biological behaviors and immune escape of pancreatic carcinoma cells
  55. IRF6 and FGF1 polymorphisms in non-syndromic cleft lip with or without cleft palate in the Polish population
  56. Comprehensive analysis of the role of SFXN family in breast cancer
  57. Efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in lung squamous cell carcinoma patients underwent conventional chemoradiotherapy
  58. Silencing of long noncoding RNA MIAT inhibits the viability and proliferation of breast cancer cells by promoting miR-378a-5p expression
  59. AG1024, an IGF-1 receptor inhibitor, ameliorates renal injury in rats with diabetic nephropathy via the SOCS/JAK2/STAT pathway
  60. Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition
  61. Exendin-4 regulates the MAPK and WNT signaling pathways to alleviate the osteogenic inhibition of periodontal ligament stem cells in a high glucose environment
  62. Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3
  63. The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma
  64. Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
  65. Ultrasound examination supporting CT or MRI in the evaluation of cervical lymphadenopathy in patients with irradiation-treated head and neck cancer
  66. F-box and WD repeat domain containing 7 inhibits the activation of hepatic stellate cells by degrading delta-like ligand 1 to block Notch signaling pathway
  67. Knockdown of circ_0005615 enhances the radiosensitivity of colorectal cancer by regulating the miR-665/NOTCH1 axis
  68. Long noncoding RNA Mhrt alleviates angiotensin II-induced cardiac hypertrophy phenotypes by mediating the miR-765/Wnt family member 7B pathway
  69. Effect of miR-499-5p/SOX6 axis on atrial fibrosis in rats with atrial fibrillation
  70. Cholesterol induces inflammation and reduces glucose utilization
  71. circ_0004904 regulates the trophoblast cell in preeclampsia via miR-19b-3p/ARRDC3 axis
  72. NECAB3 promotes the migration and invasion of liver cancer cells through HIF-1α/RIT1 signaling pathway
  73. The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
  74. miR-2053 inhibits the growth of ovarian cancer cells by downregulating SOX4
  75. Nucleophosmin 1 associating with engulfment and cell motility protein 1 regulates hepatocellular carcinoma cell chemotaxis and metastasis
  76. α-Hederin regulates macrophage polarization to relieve sepsis-induced lung and liver injuries in mice
  77. Changes of microbiota level in urinary tract infections: A meta-analysis
  78. Identification of key enzalutamide-resistance-related genes in castration-resistant prostate cancer and verification of RAD51 functions
  79. Falls during oxaliplatin-based chemotherapy for gastrointestinal malignancies – (lessons learned from) a prospective study
  80. Outcomes of low-risk birth care during the Covid-19 pandemic: A cohort study from a tertiary care center in Lithuania
  81. Vitamin D protects intestines from liver cirrhosis-induced inflammation and oxidative stress by inhibiting the TLR4/MyD88/NF-κB signaling pathway
  82. Integrated transcriptome analysis identifies APPL1/RPS6KB2/GALK1 as immune-related metastasis factors in breast cancer
  83. Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
  84. Circular RNA Circ_0038467 promotes the maturation of miRNA-203 to increase lipopolysaccharide-induced apoptosis of chondrocytes
  85. An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy
  86. Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
  87. Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
  88. PTPN12 down-regulated by miR-146b-3p gene affects the malignant progression of laryngeal squamous cell carcinoma
  89. miR-141-3p accelerates ovarian cancer progression and promotes M2-like macrophage polarization by targeting the Keap1-Nrf2 pathway
  90. lncRNA OIP5-AS1 attenuates the osteoarthritis progression in IL-1β-stimulated chondrocytes
  91. Overexpression of LINC00607 inhibits cell growth and aggressiveness by regulating the miR-1289/EFNA5 axis in non-small-cell lung cancer
  92. Subjective well-being in informal caregivers during the COVID-19 pandemic
  93. Nrf2 protects against myocardial ischemia-reperfusion injury in diabetic rats by inhibiting Drp1-mediated mitochondrial fission
  94. Unfolded protein response inhibits KAT2B/MLKL-mediated necroptosis of hepatocytes by promoting BMI1 level to ubiquitinate KAT2B
  95. Bladder cancer screening: The new selection and prediction model
  96. circNFATC3 facilitated the progression of oral squamous cell carcinoma via the miR-520h/LDHA axis
  97. Prone position effect in intensive care patients with SARS-COV-2 pneumonia
  98. Clinical observation on the efficacy of Tongdu Tuina manipulation in the treatment of primary enuresis in children
  99. Dihydroartemisinin ameliorates cerebral I/R injury in rats via regulating VWF and autophagy-mediated SIRT1/FOXO1 pathway
  100. Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway
  101. Low Ang-(1–7) and high des-Arg9 bradykinin serum levels are correlated with cardiovascular risk factors in patients with COVID-19
  102. Effect of maternal age and body mass index on induction of labor with oral misoprostol for premature rupture of membrane at term: A retrospective cross-sectional study
  103. Potential protective effects of Huanglian Jiedu Decoction against COVID-19-associated acute kidney injury: A network-based pharmacological and molecular docking study
  104. Clinical significance of serum MBD3 detection in girls with central precocious puberty
  105. Clinical features of varicella-zoster virus caused neurological diseases detected by metagenomic next-generation sequencing
  106. Collagen treatment of complex anorectal fistula: 3 years follow-up
  107. LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through down-regulating SP-A by sponging to miR-424
  108. Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen – An open-label, randomized trial
  109. SMOC2 plays a role in heart failure via regulating TGF-β1/Smad3 pathway-mediated autophagy
  110. A prospective cohort study of the impact of chronic disease on fall injuries in middle-aged and older adults
  111. circRNA THBS1 silencing inhibits the malignant biological behavior of cervical cancer cells via the regulation of miR-543/HMGB2 axis
  112. hsa_circ_0000285 sponging miR-582-3p promotes neuroblastoma progression by regulating the Wnt/β-catenin signaling pathway
  113. Long non-coding RNA GNAS-AS1 knockdown inhibits proliferation and epithelial–mesenchymal transition of lung adenocarcinoma cells via the microRNA-433-3p/Rab3A axis
  114. lncRNA UCA1 regulates miR-132/Lrrfip1 axis to promote vascular smooth muscle cell proliferation
  115. Twenty-four-color full spectrum flow cytometry panel for minimal residual disease detection in acute myeloid leukemia
  116. Hsa-miR-223-3p participates in the process of anthracycline-induced cardiomyocyte damage by regulating NFIA gene
  117. Anti-inflammatory effect of ApoE23 on Salmonella typhimurium-induced sepsis in mice
  118. Analysis of somatic mutations and key driving factors of cervical cancer progression
  119. Hsa_circ_0028007 regulates the progression of nasopharyngeal carcinoma through the miR-1179/SQLE axis
  120. Variations in sexual function after laparoendoscopic single-site hysterectomy in women with benign gynecologic diseases
  121. Effects of pharmacological delay with roxadustat on multi-territory perforator flap survival in rats
  122. Analysis of heroin effects on calcium channels in rat cardiomyocytes based on transcriptomics and metabolomics
  123. Risk factors of recurrent bacterial vaginosis among women of reproductive age: A cross-sectional study
  124. Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells
  125. Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients
  126. Correlation between microvessel maturity and ISUP grades assessed using contrast-enhanced transrectal ultrasonography in prostate cancer
  127. The protective effect of caffeic acid phenethyl ester in the nephrotoxicity induced by α-cypermethrin
  128. Norepinephrine alleviates cyclosporin A-induced nephrotoxicity by enhancing the expression of SFRP1
  129. Effect of RUNX1/FOXP3 axis on apoptosis of T and B lymphocytes and immunosuppression in sepsis
  130. The function of Foxp1 represses β-adrenergic receptor transcription in the occurrence and development of bladder cancer through STAT3 activity
  131. Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU
  132. Calycosin protects against chronic prostatitis in rats via inhibition of the p38MAPK/NF-κB pathway
  133. Pan-cancer analysis of the PDE4DIP gene with potential prognostic and immunotherapeutic values in multiple cancers including acute myeloid leukemia
  134. The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
  135. Circ-UBR4 regulates the proliferation, migration, inflammation, and apoptosis in ox-LDL-induced vascular smooth muscle cells via miR-515-5p/IGF2 axis
  136. Clinical characteristics of current COVID-19 rehabilitation outpatients in China
  137. Luteolin alleviates ulcerative colitis in rats via regulating immune response, oxidative stress, and metabolic profiling
  138. miR-199a-5p inhibits aortic valve calcification by targeting ATF6 and GRP78 in valve interstitial cells
  139. The application of iliac fascia space block combined with esketamine intravenous general anesthesia in PFNA surgery of the elderly: A prospective, single-center, controlled trial
  140. Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
  141. The effects of progesterone on the healing of obstetric anal sphincter damage in female rats
  142. Identification of cuproptosis-related genes for predicting the development of prostate cancer
  143. Lumican silencing ameliorates β-glycerophosphate-mediated vascular smooth muscle cell calcification by attenuating the inhibition of APOB on KIF2C activity
  144. Targeting PTBP1 blocks glutamine metabolism to improve the cisplatin sensitivity of hepatocarcinoma cells through modulating the mRNA stability of glutaminase
  145. A single center prospective study: Influences of different hip flexion angles on the measurement of lumbar spine bone mineral density by dual energy X-ray absorptiometry
  146. Clinical analysis of AN69ST membrane continuous venous hemofiltration in the treatment of severe sepsis
  147. Antibiotics therapy combined with probiotics administered intravaginally for the treatment of bacterial vaginosis: A systematic review and meta-analysis
  148. Construction of a ceRNA network to reveal a vascular invasion associated prognostic model in hepatocellular carcinoma
  149. A pan-cancer analysis of STAT3 expression and genetic alterations in human tumors
  150. A prognostic signature based on seven T-cell-related cell clustering genes in bladder urothelial carcinoma
  151. Pepsin concentration in oral lavage fluid of rabbit reflux model constructed by dilating the lower esophageal sphincter
  152. The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
  153. Tanshinone IIA attenuates valvular interstitial cells’ calcification induced by oxidized low density lipoprotein via reducing endoplasmic reticulum stress
  154. AS-IV enhances the antitumor effects of propofol in NSCLC cells by inhibiting autophagy
  155. Establishment of two oxaliplatin-resistant gallbladder cancer cell lines and comprehensive analysis of dysregulated genes
  156. Trial protocol: Feasibility of neuromodulation with connectivity-guided intermittent theta-burst stimulation for improving cognition in multiple sclerosis
  157. LncRNA LINC00592 mediates the promoter methylation of WIF1 to promote the development of bladder cancer
  158. Factors associated with gastrointestinal dysmotility in critically ill patients
  159. Mechanisms by which spinal cord stimulation intervenes in atrial fibrillation: The involvement of the endothelin-1 and nerve growth factor/p75NTR pathways
  160. Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics
  161. Silencing USP19 alleviates cigarette smoke extract-induced mitochondrial dysfunction in BEAS-2B cells by targeting FUNDC1
  162. Menstrual irregularities associated with COVID-19 vaccines among women in Saudi Arabia: A survey during 2022
  163. Ferroptosis involves in Schwann cell death in diabetic peripheral neuropathy
  164. The effect of AQP4 on tau protein aggregation in neurodegeneration and persistent neuroinflammation after cerebral microinfarcts
  165. Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
  166. Analysis of clinical characteristics in proximal and distal reflux monitoring among patients with gastroesophageal reflux disease
  167. Exosomal circ-0020887 and circ-0009590 as novel biomarkers for the diagnosis and prediction of short-term adverse cardiovascular outcomes in STEMI patients
  168. Upregulated microRNA-429 confers endometrial stromal cell dysfunction by targeting HIF1AN and regulating the HIF1A/VEGF pathway
  169. Bibliometrics and knowledge map analysis of ultrasound-guided regional anesthesia
  170. Knockdown of NUPR1 inhibits angiogenesis in lung cancer through IRE1/XBP1 and PERK/eIF2α/ATF4 signaling pathways
  171. D-dimer trends predict COVID-19 patient’s prognosis: A retrospective chart review study
  172. WTAP affects intracranial aneurysm progression by regulating m6A methylation modification
  173. Using of endoscopic polypectomy in patients with diagnosed malignant colorectal polyp – The cross-sectional clinical study
  174. Anti-S100A4 antibody administration alleviates bronchial epithelial–mesenchymal transition in asthmatic mice
  175. Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma
  176. Prevalence and antibiogram of bacteria causing urinary tract infection among patients with chronic kidney disease
  177. Reactive oxygen species within the vaginal space: An additional promoter of cervical intraepithelial neoplasia and uterine cervical cancer development?
  178. Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma
  179. A new technique for uterine-preserving pelvic organ prolapse surgery: Laparoscopic rectus abdominis hysteropexy for uterine prolapse by comparing with traditional techniques
  180. Self-isolation of an Italian long-term care facility during COVID-19 pandemic: A comparison study on care-related infectious episodes
  181. A comparative study on the overlapping effects of clinically applicable therapeutic interventions in patients with central nervous system damage
  182. Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome: Long-term follow-up
  183. The diagnostic accuracy of touch imprint cytology for sentinel lymph node metastases of breast cancer: An up-to-date meta-analysis of 4,073 patients
  184. Mortality associated with Sjögren’s syndrome in the United States in the 1999–2020 period: A multiple cause-of-death study
  185. CircMMP11 as a prognostic biomarker mediates miR-361-3p/HMGB1 axis to accelerate malignant progression of hepatocellular carcinoma
  186. Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations
  187. KMT2A maintains stemness of gastric cancer cells through regulating Wnt/β-catenin signaling-activated transcriptional factor KLF11
  188. Evaluation of placental oxygenation by near-infrared spectroscopy in relation to ultrasound maturation grade in physiological term pregnancies
  189. The role of ultrasonographic findings for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer
  190. Construction of immunogenic cell death-related molecular subtypes and prognostic signature in colorectal cancer
  191. Long-term prognostic value of high-sensitivity cardiac troponin-I in patients with idiopathic dilated cardiomyopathy
  192. Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients
  193. Integrative bioinformatics analysis reveals STAT2 as a novel biomarker of inflammation-related cardiac dysfunction in atrial fibrillation
  194. Adipose-derived stem cells repair radiation-induced chronic lung injury via inhibiting TGF-β1/Smad 3 signaling pathway
  195. Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000–2016 cohort
  196. lncRNA LENGA sponges miR-378 to promote myocardial fibrosis in atrial fibrillation
  197. Diagnostic value of urinary Tamm-Horsfall protein and 24 h urine osmolality for recurrent calcium oxalate stones of the upper urinary tract: Cross-sectional study
  198. The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer
  199. The spike protein of SARS-CoV-2 induces inflammation and EMT of lung epithelial cells and fibroblasts through the upregulation of GADD45A
  200. Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
  201. MiR-1278 targets CALD1 and suppresses the progression of gastric cancer via the MAPK pathway
  202. Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson’s disease after dietary supplementation with branched-chain amino acids
  203. Cimifugin inhibits adipogenesis and TNF-α-induced insulin resistance in 3T3-L1 cells
  204. Predictors of gastrointestinal complaints in patients on metformin therapy
  205. Prescribing patterns in patients with chronic obstructive pulmonary disease and atrial fibrillation
  206. A retrospective analysis of the effect of latent tuberculosis infection on clinical pregnancy outcomes of in vitro fertilization–fresh embryo transferred in infertile women
  207. Appropriateness and clinical outcomes of short sustained low-efficiency dialysis: A national experience
  208. miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD
  209. Clinical features and management of lymphoepithelial cyst
  210. Serum VEGF, high-sensitivity CRP, and cystatin-C assist in the diagnosis of type 2 diabetic retinopathy complicated with hyperuricemia
  211. ENPP1 ameliorates vascular calcification via inhibiting the osteogenic transformation of VSMCs and generating PPi
  212. Significance of monitoring the levels of thyroid hormone antibodies and glucose and lipid metabolism antibodies in patients suffer from type 2 diabetes
  213. The causal relationship between immune cells and different kidney diseases: A Mendelian randomization study
  214. Interleukin 33, soluble suppression of tumorigenicity 2, interleukin 27, and galectin 3 as predictors for outcome in patients admitted to intensive care units
  215. Identification of diagnostic immune-related gene biomarkers for predicting heart failure after acute myocardial infarction
  216. Long-term administration of probiotics prevents gastrointestinal mucosal barrier dysfunction in septic mice partly by upregulating the 5-HT degradation pathway
  217. miR-192 inhibits the activation of hepatic stellate cells by targeting Rictor
  218. Diagnostic and prognostic value of MR-pro ADM, procalcitonin, and copeptin in sepsis
  219. Review Articles
  220. Prenatal diagnosis of fetal defects and its implications on the delivery mode
  221. Electromagnetic fields exposure on fetal and childhood abnormalities: Systematic review and meta-analysis
  222. Characteristics of antibiotic resistance mechanisms and genes of Klebsiella pneumoniae
  223. Saddle pulmonary embolism in the setting of COVID-19 infection: A systematic review of case reports and case series
  224. Vitamin C and epigenetics: A short physiological overview
  225. Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients
  226. Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
  227. Mechanism of rhubarb in the treatment of hyperlipidemia: A recent review
  228. Surgical management and outcomes of traumatic global brachial plexus injury: A concise review and our center approach
  229. The progress of autoimmune hepatitis research and future challenges
  230. METTL16 in human diseases: What should we do next?
  231. New insights into the prevention of ureteral stents encrustation
  232. VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature
  233. Case Reports
  234. Mycobacterium xenopi infection of the kidney and lymph nodes: A case report
  235. Genetic mutation of SLC6A20 (c.1072T > C) in a family with nephrolithiasis: A case report
  236. Chronic hepatitis B complicated with secondary hemochromatosis was cured clinically: A case report
  237. Liver abscess complicated with multiple organ invasive infection caused by hematogenous disseminated hypervirulent Klebsiella pneumoniae: A case report
  238. Urokinase-based lock solutions for catheter salvage: A case of an upcoming kidney transplant recipient
  239. Two case reports of maturity-onset diabetes of the young type 3 caused by the hepatocyte nuclear factor 1α gene mutation
  240. Immune checkpoint inhibitor-related pancreatitis: What is known and what is not
  241. Does total hip arthroplasty result in intercostal nerve injury? A case report and literature review
  242. Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi – Case report and literature review
  243. Synchronous triple primary gastrointestinal malignant tumors treated with laparoscopic surgery: A case report
  244. CT-guided percutaneous microwave ablation combined with bone cement injection for the treatment of transverse metastases: A case report
  245. Malignant hyperthermia: Report on a successful rescue of a case with the highest temperature of 44.2°C
  246. Anesthetic management of fetal pulmonary valvuloplasty: A case report
  247. Rapid Communication
  248. Impact of COVID-19 lockdown on glycemic levels during pregnancy: A retrospective analysis
  249. Erratum
  250. Erratum to “Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway”
  251. Erratum to: “Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p”
  252. Retraction
  253. Retraction of “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients”
  254. Retraction of “circ_0062491 alleviates periodontitis via the miR-142-5p/IGF1 axis”
  255. Retraction of “miR-223-3p alleviates TGF-β-induced epithelial-mesenchymal transition and extracellular matrix deposition by targeting SP3 in endometrial epithelial cells”
  256. Retraction of “SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis”
  257. Retraction of “circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury”
  258. Retraction of “lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells”
  259. Special issue Linking Pathobiological Mechanisms to Clinical Application for cardiovascular diseases
  260. Effect of cardiac rehabilitation therapy on depressed patients with cardiac insufficiency after cardiac surgery
  261. Special issue The evolving saga of RNAs from bench to bedside - Part I
  262. FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma
  263. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part III
  264. Development of a machine learning-based signature utilizing inflammatory response genes for predicting prognosis and immune microenvironment in ovarian cancer
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2023-0785/html
Scroll to top button